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p38 MAPK and MAPK kinase 3/6 mRNA and activities are cellular hypertrophy [1, 2], increased production of extra-
increased in early diabetic glomeruli. cellular matrix protein (ECM) [3, 4], and decreased pro-
Background. The p38 mitogen-activated protein kinase duction of matrix-degrading proteinases [5, 6], the under-(MAPK) pathway is activated by several stress factors, poten-
lying signal transduction mechanisms mediating thesetially leading to cellular apoptosis and growth. Little is known
processes have been less well explored.about the pattern of glomerular p38 MAPK pathway activation
during the course of diabetic nephropathy (DN). We examined Numerous studies reveal protein kinase C (PKC) acti-
the activity and expression of the p38 MAPK pathway mem- vation in diabetic glomeruli [7] and in mesangial cells
bers, p38 MAPK, MKK3/6, cAMP-responsive element binding cultured under high-glucose conditions [8, 9]. PKC prop-protein (CREB), and MAPK phosphatase-1 (MKP-1), in ex-
agates the physiologic responses of receptor-ligand inter-perimental DN in rats over the course of four months.
Methods. Control (C; N  16) and diabetic (DM; N  16) actions via an array of downstream signals, such as mito-
rats were studied. Four rats from each group were sacrificed gen-activated protein kinases (MAPKs). Ultimately, these
monthly, and competitive reverse transcription-polymerase transmitted signals regulate the transcription of genes
chain reaction and Western blot were performed with microdis-
responsible for key cellular responses such as prolifera-sected and sieved glomeruli, respectively.
tion, differentiation, and apoptosis [10–12].Results. Glomerular p38 MAPK mRNA expression was sig-
nificantly higher in DM than C (P  0.01) throughout the The MAPK family includes the extracellular signal-
four-month period. Western blot revealed an average 3.1-fold regulated kinase-1/2 (ERK1/2) or p42/44 MAPK [12, 13],
increase in p38 MAPK protein throughout the study period stress-activated c-Jun N-amino terminal kinase (JNK/(P  0.05). However, p38 MAPK activity was significantly
stress-activated protein kinase or SAPK) [11, 12, 14],increased only in one- and two-month diabetic glomeruli. Glo-
p38 MAPK [15–17], and big MAPK (ERK 5) [18]. Themerular MKK3/6 and CREB mRNA as well as activity were
significantly increased only in one- and two-month DM com- classic MAPK ERK1/2 plays a pivotal role in growth
pared with C. MKP-1 mRNA showed a similar pattern. factor-induced mitogenesis, differentiation, and cellular
Conclusions. Glomerular p38 MAPK activity was increased
transformation. ERK1/2 is activated through a Ras-in early DN. Parallel to this, we also showed, to our knowledge
dependent signal transduction pathway by hormones andfor the first time, that there were increased MKK3/6 and CREB
activities and mRNA expression. This activated p38 MAPK growth factors. It leads to cellular proliferation and dif-
pathway in diabetic glomeruli may, in part, play a role in the ferentiation by stimulating transcription factors that in-
pathogenesis of early hypertrophy and extracellular matrix ac- duce the expression of c-fos and other growth-responsivecumulation.
genes [10, 12, 13]. JNK/SAPK and p38 MAPK represent
two independent parallel MAPK pathways that are acti-
vated in response to stress signals such as proinflamma-
The molecular and cellular mechanisms responsible
tory cytokines [11, 14–16, 19], ultraviolet irradiation [14],for diabetic nephropathy (DN) remain incompletely re-
osmolality changes [15], and oxidants [20], leading tosolved. While studies indicate involvement of hyper-
alterations in cell growth, prostanoid production, andglycemia via the stimulation of growth factor-induced
other cellular dysfunction [21, 22].
Since hyperosmolality and oxidant stress characterize
the diabetic state, p38 MAPK has been posited to medi-Key words: hypertrophy, extracellular matrix, p38 MAPK, renal glo-
meruli, CREB. ate the pathogenesis of diabetic complications. Increased
p38 MAPK activity has been observed in the aorta ofReceived for publication December 29, 2000
diabetic rats and in vascular smooth muscle cells culturedand in revised form March 8, 2001
Accepted for publication March 12, 2001 under high-glucose conditions [23, 24]. Increased mesan-
gial cell p38 MAPK activity has been identified in associ- 2001 by the International Society of Nephrology
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ation with high glucose culture conditions [25] and with HCl, pH 6.8, 10% (vol/vol) glycerol]. The lysate was
mechanical strain [26], the latter also activating ERK1/2. centrifuged at 10,000  g for 10 minutes at 4C, and
However, the p38 MAPK pathway has heretofore not the supernatant was stored at 70C until all rats were
been extensively studied in diabetic glomeruli, and little sacrificed. Protein concentrations were determined with
is known about time-course changes of MAPK in experi- a Bio-Rad kit (Bio-Rad Laboratories, Hercules, CA,
mental DN in vivo. Furthermore, there are no reports USA). Aliquots of 50 g protein were treated with
regarding the regulation of the upstream kinase activators Laemmli sample buffer, heated at 100C for five minutes,
of p38 MAPK, namely MKK3/6 under diabetic conditions. electrophoresed, and transferred to Hybond-ECL mem-
This study examined the p38 MAPK pathway in glo- branes (Amersham Life Science, Inc., Arlington Heights,
meruli isolated from streptozotocin-induced diabetic rats IL, USA). Blocked membranes were incubated over-
one, two, three, and four months after diabetes induction. night at 4C with a 1:1000 dilution of polyclonal antibody
Besides p38 MAPK, we also studied (1) MKK3 and to p38 MAPK, phospho-specific p38 MAPK, phospho-
MKK6, which are upstream activators of p38 MAPK specific MKK3/6, or phospho-specific CREB (New En-
[27, 28]; (2) cAMP-responsive element binding protein gland Biolabs, Inc., Beverly, MA, USA). This was fol-
(CREB), a transcription factor that could be activated lowed by incubation with horseradish peroxidase-linked
by protein kinase A (PKA) as well as p38 MAPK [29–31];
sheep anti-mouse IgG (Amersham) at 1:1000 dilution.
and (3) MAPK phosphatase-1 (MKP-1), a phosphatase
Developing was with a chemiluminescent agent (ECL;that dephosphorylates tyrosine and threonine residues
Amersham).of p38 MAPK, resulting in deactivation of p38 MAPK
[32]. In the present study, we have examined not only Microdissection, total RNA extraction, and
the activities of these key signaling kinases and target reverse transcription
transcription factor, but also their mRNA expression
Glomerular microdissection, total RNA extraction,during the course of DN. We also correlated these with
and reverse transcription (RT) were performed as de-the expression of fibronectin and transforming growth
scribed recently [33].factor- (TGF-), key markers of DN.
Semiquantitative competitive PCR
METHODS Competitor cDNAs were used as internal standards
Animals in semiquantitative PCR evaluation of GAPDH, p38
All animal studies were conducted under an approved MAPK, MKK3, MKK6, CREB, fibronectin, MKP-1, and
institutional protocol. Sprague-Dawley rats weighing 220 TGF- mRNAs. Each competitor was designed to con-
to 250 g were injected intraperitoneally with either dilu- tain the same base-pair sequence as the target cDNA,
ent [N  16, control (C)] or 65 mg/kg streptozotocin but had a portion deleted so that the competitor PCR-
(STZ) [N  16, diabetes (DM)]. Blood glucose levels generated fragment could be easily distinguished electro-
were measured on the third day after STZ injection to phoretically by size. The primers used are summarized
confirm the development of diabetes. Rats were housed in Table 1. cDNA from 1/10 of a glomerulus per reaction
in a temperature-controlled room and were given free tube was used for GAPDH and fibronectin, 1/5 of a
access to water and standard laboratory chow during the glomerulus for p38 MAPK, and 1/2 glomerulus for the
four-month study period. Four rats from each group were remainder. PCR was performed using the test or wild-
sacrificed at the end of one, two, three, or four months. type cDNA, Taq-Gold polymerase (1.5 U for GAPDH,
Sieved glomeruli obtained from the one- to four-month p38 MAPK, and fibronectin; 2.5 U for the remainder),
rats were used for Western blots, while microdissected
20 mol/L dNTP, sense and antisense primers (25 pmol
glomeruli from the one-, two-, and four-month rats were
for GAPDH, p38 MAPK, and fibronectin; 30 pmol forused for RNA extraction and polymerase chain reactions
the remainder), and specific dilution of competitor in a(PCRs). Blood glucose levels of the control rats at one,
volume of 50 L containing 1  PCR buffer. The PCRtwo, three, and four months were as follows: 103.1 4.5,
conditions were denaturation at 95C for 45 seconds,106.5  2.4, 102.2  4.8, 95.4  3.8, and 104.5  6.9,
annealing at corresponding temperature for 45 seconds,respectively. Blood glucose levels in the diabetic rats
and extension at 72C for two minutes (Table 1). Initialwere 438.8  18.6 at three days post-STZ, 453.0  18.8
heating at 95C for nine minutes and final extension atat one month, 441.4  23.2 at two months, 447.5  15.2
72C for seven minutes was performed for all PCRs. Theat three months, and 494.3  17.8 at four months.
RT-PCR products were separated by electrophoresis.
Western blot analysis Band densities were analyzed by laser densitometry
(Helena Laboratories, Beaumont, TX, USA), and theSieved rat glomeruli were lysed in sodium dodecyl
sulfate (SDS) sample buffer [2% SDS, 10 mmol/L Tris- ratio of wild type to competitor was used for analyses.
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Table 1. Primers sequences and PCR conditions
Annealing
Sequence (5	 → 3	) temperature C No. of cycles
GAPDH
Sense GACAAGATGGTGAAGGTCGG 62 36
Antisense CATGGACTGTGGTCATGAGC
P38 MAPK
Sense CGAAATGACCGGCTACGTGG 65 40
Antisense CACTTCATCGTAGGTCAGGC
MKK3
Sense GCCTTCCAATGTCCTCATCAAC 62 48
Antisense GGATTCTTCCTGAGGCACTGG
MKK6
Sense GGTGGAGAAGATGCGTCACG 62 48
Antisense CCAGGTAGCCGCTGATTCC
MKP-1
Sense GCTTCAGCACCATCGTGC 63 45
Antisense GCATGGTAAGCACTGCCC
CREB
Sense GGGAAATCCTTTCAAGGAGGC 61 42
Antisense CGACATTCTCTTGCTGCTTCC
Fibronectin
Sense GCAAGCCTGAACCTGAAGAGACC 62 38
Antisense CCTGGTGTCCTGATCATTGCATC
TGF-
Sense CGAGGTGACCTGGGCACCATCC 62 42
Antisense GCTCCACCTTGGGCTTGCGACC
Abbreviations are in the Appendix.
Statistical analysis isoforms, lower panel). Interestingly, phospho-specific
p38 MAPK levels, which represent p38 MAPK activity,All values are expressed as the mean  SEM. Statisti-
were greater in the diabetic rats relative to the corre-cal analysis was performed using the statistical package
sponding control rats at one and two months (P  0.01SPSS for Windows version 7.51 (SPSS, Inc., Chicago, IL,
at each time), but decreased to control levels thereafter.USA). Results were analyzed using the Student t test or
In contrast, although total p38 levels (lower panel) wereanalysis of variance (ANOVA) for multiple comparisons.
unchanged from one to four months in each group alone,
they were significantly elevated (3-fold) in the diabetic
RESULTS glomeruli compared with control at all four time points
(P 0.05). The ratios of phospho-p38 to total p38 MAPKA time-course study was performed wherein the activi-
ties as well as mRNA expression were simultaneously levels were significantly greater in DM glomeruli only
at one and two months (P 0.01). Equal protein loadingexamined of p38 MAPK, MKK3/6 (upstream activators
of p38 MAPK), and CREB, in addition to MKP-1 was confirmed by Coomassie Blue staining of the gel.
To evaluate whether this increase in p38 MAPK ex-mRNA in glomeruli isolated from control rats versus
rats that had been diabetic for one to four months. To pression in DM glomeruli was also regulated at the
mRNA level, total RNA from microdissected glomerulicorrelate these parameters to the progression of DN,
mRNA expression of the key ECM protein fibronectin from the one-, two- and four-month study were used.
We developed a new competitive PCR using primersas well as transforming growth factor- (TGF-) also
were evaluated. derived from the sequence of rat p38 MAPK [15]. The
p38 MAPK mRNA ratios (wild-type:competitor) were
p38 MAPK activity, protein, and mRNA expression significantly greater in DM rats than the corresponding
C and were over twofold greater at all three time pointsWe first examined whether p38 MAPK activity, pro-
tein, as well as mRNA expression were altered in the studied (Fig. 2). In contrast, glomerular GAPDH mRNA
ratios (wild-type:competitor) in the DM glomeruli didone- to four-month time period after STZ injection. Fig-
ure 1 shows a representative Western blot of equal not differ from those in the C group (data not shown).
p38 MAPK mRNA ratios remained significantly higheramounts of protein from lysates of sieved glomeruli from
the control and DM rats at one to four months. The blot in DM relative to corresponding C after correction for
GAPDH mRNA ratios (Fig. 3).was first probed with an antibody to phospho-specific
p38 MAPK (upper panel), stripped, and then probed Thus, total p38 MAPK protein and mRNA expression
are increased in experimental DN, but a new level ofwith an antibody that recognizes total p38 MAPK (all
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Fig. 1. Western blot of glomerular total and phospho-specific p38 mitogen-activated protein kinase (MAPK) in control and diabetic (DM) rats
(representative of four blots). Total p38 MAPK protein expression (lower panel) was significantly higher in DM than control throughout the four
months (average 3.1-fold increase by densitometry, P  0.05). On the other hand, activated phospho-specific p38 MAPK protein (upper panel)
showed a significant increase only in one- and two-month DM glomeruli (P  0.001).
Fig. 2. Glomerular p38 MAPK mRNA RT-PCR in one-, two-, and four-month control and DM rats. Each lane represents a competitive RT-
PCR reaction (40 cycles) of RNA from microdissected glomeruli. A fixed amount of p38 MAPK wild-type cDNA (476 bp) from the equivalent
of 0.2 glomeruli from each rat and fixed amount of p38 MAPK competitor cDNA (355 bp) were used. All data are expressed as the ratio of wild-
type:competitor optical density after densitometric analyses. Data shown are representative of four gels.
regulation of p38 MAPK enzyme activity is operative in relative to control, but not thereafter (1.8- and 2.1-fold
increments at one and two months, respectively, P the early versus later stages of DN.
0.05). This trend was similar to phospho-specific p38
MKK3/6 activity and mRNA expression MAPK (Fig. 1, upper panel).
Since DM seemed to up-regulate MKK3/6 activity, weThe activity and mRNA expression of the upstream
kinase activators of p38 MAPK, namely, MKK3/6, were wanted to determine whether this was related to mRNA
expression. Here again, we successfully developed aexamined. The blot shown in Figure 1 was stripped and
reprobed with an antibody that recognizes both phos- specific competitive PCR approach to evaluate MKK3
and MKK6 mRNA levels. Glomerular MKK3 as well aspho-specific MKK3 and MKK6 (activated forms of these
kinases). This representative Western blot seen in Fig- MKK6 mRNA ratios (wild-type:competitor) were signifi-
cantly higher in the one- and two-month DM rats com-ure 4 shows that phospho-specific MKK3/6 levels were
also increased in one- and two-month diabetic glomeruli pared with corresponding C rats, but unlike p38 MAPK
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mRNA expression at one and two months, respectively
(Fig. 8). These results show for the first time that in-
creased CREB activity in early DN may be a conse-
quence of increased activity of its upstream kinase activa-
tors as well as increased CREB mRNA expression.
MKP-1 mRNA expression
To determine whether the fall in p38 MAPK and
MKK3/6 activities in later time periods was due to the ac-
tion of a phosphatase, the expression of MKP-1 mRNA
also was examined by competitive PCR. Glomerular
MKP-1 mRNA ratios (wild-type:competitor) were signif-
icantly greater in DM versus C only at one and two months,
Fig. 3. Glomerular p38 MAPK mRNA ratio:GAPDH mRNA ratio of but not at four months, both before (data not shown)
the rats. Ratio equals the optical density of wild-type band to the optical and after correction for GAPDH ratios (Fig. 9). Hence,
density of the competitor band. p38 MAPK mRNA ratios were then
the fall-off in kinase activities after two months couldcorrected for the GAPDH mRNA ratio. These ratios were significantly
higher in DM compared with corresponding control rats throughout not be attributed to changes in MKP-1 mRNA levels.
the four-month study. Symbols are: () 1 month; ( ) 2 months; ( )
4 months; *P  0.05 vs. control; #P  0.01 vs. control. Fibronectin and TGF- mRNA expression
To correlate these observations to evolving DN, the
mRNA expression of the key matrix protein, fibronectin,
as well that of the growth factor, TGF-, were examinedmRNA, the MKK3/6 mRNAs returned to control levels
at four months. After correcting for GAPDH mRNA using semiquantitative competitive PCR. The glomeru-
ratios in each sample, there remained a significant, nearly lar fibronectin mRNA ratio (wild-type:competitor) was
twofold increase in MKK3 and MKK6 mRNAs at one- significantly higher in the DM relative to the correspond-
and two-month time periods, but not at four months ing C rats throughout the four-month period before (data
(Figs. 5 and 6). not shown) and after correction for GAPDH mRNA
These results demonstrate, to our knowledge for the levels (P  0.005; Fig. 10).
first time, the regulation of MKKs under diabetic condi- Similarly, glomerular TGF-mRNA ratios (wild-type:
tions, and also suggest a new level of potential transcrip- competitor) were significantly greater in the DM rats
tional regulation of p38 MAPK family signaling mole- relative to corresponding C rats throughout the four-
cules in DN. month period before (data not shown) and after correc-
tion for GAPDH mRNA levels (P  0.01; Fig. 11).
CREB activity and mRNA expression Thus, glomerular mRNA levels of all the factors exam-
To determine whether activation of the p38 MAPK ined, p38 MAPK, MKK3/6, CREB, MKP-1, fibronectin,
pathway could induce parallel increases in the activity and TGF- (except the GAPDH control), were signifi-
of a p38 MAPK target transcription factor, we examined cantly higher in DM compared with C rats at one and
the activity and mRNA expression of CREB due to two months after STZ or diluent injections, respectively.
its role in fibronectin transcription [34, 35]. Glomerular This suggests a p38 MAPK-regulated mechanism leading
protein lysates were subjected to immunoblotting using to fibronectin expression in early DN. However, a more
an antibody to phospho-specific (activated) CREB. The complex pattern emerges by three to four months, with
representative blot in Figure 7 shows that CREB activity increased p38 MAPK mRNA and protein expression
was significantly increased in the one- and two-month (without corresponding p38 MAPK activity), normaliza-
DM samples relative to C (P  0.005). However, similar tion of mRNAs and activities of MKK3/6 and CREB,
to p38 MAPK and MKK3/6 activities, CREB activity and nevertheless, the maintenance of increased fibro-
also declined at three and four months. nectin and TGF- mRNA expression.
We then developed a specific competitive PCR tech-
nique to evaluate CREB mRNA levels. Glomerular CREB
DISCUSSIONmRNA ratios (wild-type:competitor) were greater in the
Diabetic nephropathy is characterized by glomerularDM glomeruli compared with C at one and two months,
hypertrophy and ECM accumulation [36, 37]. Since p38but not at four months. This trend was parallel to that
MAPK is activated by cellular stressors and has beenobserved with MKK3/6 mRNAs, but different from p38
implicated in the pathogenesis of cardiac and vascularMAPK mRNA, which remained elevated even at four
smooth muscle cell hypertrophy [38, 39], TGF-–inducedmonths. After correcting for GAPDH mRNA ratios,
there were significant 1.7- and 1.8-fold increases in CREB gene expression and TGF- formation [40, 41], we fo-
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Fig. 4. Western blot of phospho-specific MAPK kinase 3/6 (MKK3/6) with control and DM glomeruli (representative of four blots). There were
1.8- and 2.1-fold increases in MKK3/6 activity in one- and two-month DM compared with the corresponding control rats, respectively (P  0.05).
Fig. 6. Glomerular MKK6 mRNA ratio:GAPDH ratio. Glomerular
MKK6 mRNA expression showed a similar pattern as MKK3 mRNA.
Fig. 5. Glomerular MKK3 mRNA ratio:GAPDH ratio of the rats. There was a significant increase in MKK6 mRNA in one- and two-
Glomerular MKK3 mRNA expression was significantly higher in one- month DM rats compared with corresponding control rats. Symbols
and two-month DM rats than in corresponding control rats and returned are: () 1 month; ( ) 2 months; ( ) 4 months; *P  0.05 vs. control.
to control level after four months. Symbols are: () 1 month; ( ) 2
months; ( ) 4 months; *P 0.05 vs. control. MKK3 mRNA expression
showed a similar pattern as the phospho-specific MKK3/6 protein expres-
sion (Fig. 4).
[23]. Other in vitro studies also demonstrated that short-
term exposure to high glucose activated p38 MAPK in
cultured rat vascular smooth muscle cells [24] and mesan-
cused on the p38 MAPK pathway rather than other gial cells [25]. However, not all investigators report in-
MAPKs to discern the effector pathways that may medi- creased p38 MAPK activity in cultured mesangial cells
ate DN. We demonstrate, to our knowledge for the first treated with high glucose [42]. These inconsistent find-
time, that glomerular p38 MAPK activity is increased ings may result from different culture conditions and/or
in early DN and that the activation of p38 MAPK is glucose concentrations utilized in these experiments. In
associated with and likely due to increased MKK3 and our current study, we observed increased p38 MAPK
MKK6 at the mRNA and activity levels. protein expression as well as activity in early diabetic
p38 MAPK is a member of the MAPK family and is glomeruli, a finding that is consistent with the aforemen-
known as a “stress-activated kinase” along with the JNK tioned study in diabetic aorta [23].
[14–17]. p38 MAPK is strongly activated by environmen- The activity of the MAPK family including p38 MAPK
tal stressors, including osmolality changes [15], oxidants is determined by a dynamic balance between phosphory-
[20], and proinflammatory cytokines [19], leading to lation and dephosphorylation, resulting from dual specific
cellular growth, differentiation, and apoptosis [21, 38]. protein kinases (MAPK kinase, MKK, or MEK) and phos-
Recent work has shown that high ambient glucose con- phatase, respectively [27, 28, 32]. Among numerous MAPK
centrations increased p38 MAPK activity in cultured vas- kinases, MKK3 and MKK6 catalyze the phosphorylation
cular smooth muscle cells via PKC-dependent and -inde- of p38 MAPK specifically and MKK4/SEK1 mediates
pendent pathways [23, 24]. Increased p38 MAPK protein the activation of both p38 MAPK and JNK [27, 28].
MKK3 and/or MKK6 are activated by factors such asand activity were also observed in aortas of diabetic rats
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Fig. 7. Western blot of glomerular phospho-specific cAMP-responsive element binding protein (CREB) in control and DM rats (representative
of three blots). Phospho-CREB levels were significantly higher in the one- and two-month DM glomeruli than in the corresponding control
glomeruli (P  0.005).
Fig. 8. Glomerular CREB mRNA ratio:GAPDH ratio of the rats. Fig. 10. Glomerular fibronectin mRNA ratio:GAPDH ratio of the rats.
CREB mRNA expression at one and two months was significantly Fibronectin mRNA expression was significantly increased in DM com-
higher in DM than control rats, but at four months, there was no pared with corresponding control glomeruli throughout the four-month
significant difference between the two groups. Symbols are: () 1 study period. Symbols are: () 1 month; ( ) 2 months; ( ) 4 months;
month; ( ) 2 months; ( ) 4 months; *P  0.05 vs. control. *P  0.005 vs. control.
Fig. 9. Glomerular MKP-1 mRNA ratio:GAPDH ratio of the rats. Fig. 11. Glomerular transforming growth factor- (TGF-) mRNA
ratio:GAPDH ratio of the rats. Glomerular TGF- mRNA expressionMAPK phosphatase-1 (MKP-1) mRNA expression was significantly
higher in one- and two-month DM than corresponding control rats. was significantly increased in DM rats compared with corresponding
control rats throughout the four-month study period. Symbols are: ()Symbols are: () 1 month; ( ) 2 months; ( ) 4 months; *P  0.005
vs. control. 1 month; ( ) 2 months; ( ) 4 months; *P  0.01 vs. control.
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osmotic shock [43] and lipopolysaccharide (LPS) [44]. (ATF-1), ATF-2, Elk-1, CHOP, and myocyte enhancer
factor-2C (MEF-2C), thereby regulating gene expressionAlthough some studies have demonstrated p38 MAPK
activation under diabetic conditions [23, 25], little is [19, 27, 29–31, 53–55]. In addition to these factors, the p38
MAPK also activates other protein kinases. Among theseknown about the upstream activators of p38 MAPK in
this setting. Haneda et al observed activation of MEK1, downstream kinases, mitogen- and stress-activated protein
kinase-1 (MSK-1), MAPK-activated protein kinase-2an upstream protein kinase of ERK1, in diabetic glomer-
uli and mesangial cells under high glucose conditions, (MAPKAPK-2), and ribosomal S6 kinase-B (RSK-B)
have been implicated in the phosphorylation of CREBbut did not assess the p38 MAPK pathway [45]. Our
study demonstrates, for the first time to our knowledge, after activation by the p38 MAPK pathway [30, 31].
CREB can lead to gene expression by binding to thethat MKK3 and MKK6 activity as well as mRNA expres-
sion is increased in early diabetic glomeruli, presumably cAMP response element (CRE). Since the fibronectin
promotor contains a CRE located 170 bp [56], acti-resulting in p38 MAPK activation. We also show for the
first time that p38 MAPK mRNA expression is increased. vated CREB can bind to this CRE, leading to fibronectin
mRNA expression. Kreisberg et al have demonstratedMitogen-activated protein kinase phosphatase-1 is a
member of the rapidly growing, dual-specific protein ty- that activation of PKC by high glucose plus TGF- or
phorbol 12 myristate 13-acetate (PMA) induced CREBrosine phosphatase family that dephosphorylates and in-
activates various members of the MAPK family [32, 46]. activation and fibronectin transcription in mesangial cells
in vitro [34]. Nahman et al have demonstrated theInitial reports regarding MKP-1 demonstrated that MKP-1
was associated with ERK both in vivo and in vitro [46], involvement of CRE elements in angiotensin II-induced
fibronectin expression in mesangial cells [35]. We nowbut recent investigations suggest that MKP-1 exhibits a
broad substrate specificity, being able to inactivate both report increased fibronectin mRNA expression along
with increased CREB mRNA and activity in early dia-JNK and p38 MAPK [20, 44]. MPK-1 is principally regu-
lated at the transcriptional level [47], as evidenced by betic glomeruli in vivo.
In these experiments, the p38 MAPK pathway wasvery low to undetectable mRNA expression in quiescent
cells and a rapid induction by multiple signaling mole- functionally activated in early diabetic glomeruli but re-
turned to the control levels with time, a new in vivocules, including growth factors and angiotensin II [32,
46, 48–52]. Most previous in vitro studies have suggested finding that is in agreement with most previous in vitro
studies. Although the mechanism of this deactivation atthat MKP-1 is implicated in a feedback loop serving
to inactivate MAPK after stimulation by mitogens or later time periods is presently unclear, it seems that more
proximal signal transduction molecules than MKK3 andcellular stress [20, 50].
Even though high glucose is known to exert cellular MKK6 may be involved. Glomerular fibronectin mRNA
expression was increased not only in early diabetic ratsstress, the effect of hyperglycemia on MKP-1 expression
remains controversial. An in vitro study of vascular smooth but also after three months, even when the p38 MAPK
pathway was already deactivated. These findings suggestcells revealed that 12 to 24 hours of incubation in high
glucose (25 mmol/L) decreased MKP-1 mRNA and pro- that fibronectin mRNA expression is not totally depen-
dent on the MKK3/6-p38MAPK-CREB axis. TGF- istein [51]. MKP-1 protein expression was also suppressed
in mesangial cells grown under high glucose (30 mmol/L) known to play an important role in the synthesis of ECM
molecules in DN [57, 58]. Previous studies have demon-for five days, resulting in activation of ERK [52]. How-
ever, Kang et al observed that MKP-1 protein was in- strated that TGF- activates at least two independent
pathways, the TGF-–activated kinase 1 (TAK1)-MKK6-creased in mesangial cells after one hour of exposure to
high glucose (40 mmol/L), sustained for 24 hours, and p38MAPK pathway and the Smad-mediated pathway
[59, 60]. Even though TGF- activates the p38 MAPKdeclined to control levels after 48 hours [25]. The reasons
for the discrepant effects of high glucose on MKP-1 are pathway, a recent study showed that dominant negative
TAK1 or dominant negative MKK6 fails to inhibit TGF-unclear, but may result from differences in cell type, use
of pooled samples, duration of high glucose exposure, –induced signal transduction in C2C12 myoblast cells
due to an intact Smad-mediated pathway [40]. In ourand glucose concentrations used. Our study found that
the time course of glomerular MKP-1 mRNA expression study, glomerular TGF- mRNA expression was signifi-
cantly higher in DM rats compared with C rats through-coincided with activation of p38 MAPK. These results
implicate MKP-1 induction in early diabetic glomeruli out the four-month study period similar to fibronectin.
This suggests that an intact TGF--Smad pathway mayas a negative feedback loop to dephosphorylate activated
MAPK including p38 MAPK, rather than a pathogenetic mediate the sustained increase in fibronectin mRNA
after three to four months when the MKK3/6-p38mechanism for p38 activation.
Once p38 MAPK is activated, it phosphorylates sev- MAPK-CREB pathway is already deactivated.
In summary, p38 MAPK activity was increased in earlyeral transcription factors at serine and threonine residues
including CREB and activating transcription factor-1 diabetic glomeruli, and this increase was associated with
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kinase C and cyclic AMP/protein kinase A in high glucose-stimu-and likely mediated by increased MKK3/6 activity and
lated transcriptional activation of collagen alpha 1(IV) in glomeru-
mRNA expression. Furthermore, the activity of CREB, lar mesangial cells. J Diabetes Compl 9:255–261, 1995
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